Fisetin – MCAS and Histamines Update

The site of this post has disappeared (https://www.syndromea.org/2019/07/23/could-fisetin-be-a-new-treatment-for-me-cfs-autism/ ) and a reader asked me to repost it’s content from a saved copy. I have done an earlier post Fisetin – an off the radar flavonoid. At the bottom I am adding some additional notes.

NOTE: Suggested dosage: for 110lb person – 1000mg/day (see Comments)

In my very first post on this site, I reported that I have a remarkable response to high dose biotin. It reduces my ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) symptoms like severe fatigue and the mental confusion that people with ME/CFS call brain fog. It also reduces my autistic symptoms, relieving anxiety and irritability while improving my ability to read people.

A natural substance called fisetin gives me similar but better results and ▪️▪️▪️fisetin’s effects can last for days and possibly weeks for me. On high dose biotin, I relapse badly if I miss a twice daily dose. I have switched from biotin to fisetin because fisetin seems to improve the function of my brain and body for longer periods of time.Fisetin is found in many fruits in vegetables, but is found in the highest quantities in strawberries.

Fisetin helps pull me out of post-exertional malaise. As a mild ME/CFS patient, I could historically expect to get a few days to a couple of weeks of postexertional malaise after mild exercise like moderate digging in my garden. With fisetin, I am able to dig significantly more without a problem and recover more quickly when I overdo it. Things like going on a bike ride around the block will trigger about 2 days of PEM instead of 5 or 7. Not a panacea, but an improvement.Day to day, in the absence of attempting to exercise, I am so much clearer and sharper mentally. My memory and focus is so much better and I feel less physically weak and forgetful.

Like a lot of autistic people and like many people with my connective tissue disorder, Ehlers-Danlos syndrome, I deal with a lot of anxiety. Three capsules of fisetin reduces my anxiety greatly within 24 hours. It’s like meditation in bottle. Fisetin also helps a great deal with the constant low level depression that I have had most of my life, that many people with autism have.A bottle of fisetin will generally tell you to take 1 capsule. I have never had results with less than three capsules and have taken 5 capsules twice daily with good effects. Fisetin has exceptionally low toxicity. Existing fisetin research might shed light on why it works for me.

✅✅Fisetin Inhibits Mast Cell Activation

Like many people with ME/CFS, Ehlers-Danlos Syndrome and autism, I also have mast cell activation syndrome (MCAS), an inflammatory disorder of a certain type of immune cell called a mast cell. MCAS caused the bouts of flushing and I hives I got when I first became ill with ME/CFS.

This 2007 article found that fisetin downregulated mast cell activation in part by suppressing one of the major inflammatory molecules in the body: NF-kappaB. NF-kappaB

NF-KappaB is considered the master regulator of the inflammatory response in the body. Indeed, fisetin has other effects in the body related to suppression of NF-KappaB activation. In animal study published last year, fisetin inhibited airway inflammation and hyperresponsiveness in an animal model of asthma by interfering with NF-KappaB. In another study, fisetin reduced signs of disease in an experimental animal model of inflammatory bowel disease. In a chronic inflammatory disorder such as ME/CFS, it might make sense to try something that broadly downregulates the inflammatory response. Ischemia-Reperfusion InjuryI actually chose fisetin to try specifically because it seems to protect the body and brain against the effects of a type of damage called ischemia-reperfusion (I/R) injury. I/R injury occurs when cells are temporarily deprived of blood and then blood is re-introduced. Cells don’t do well being deprived of oxygen, but serious damage also occurs when the oxygen supply is re-established.

I have been concerned that some version of mild I/R injury in the brain occurs in ME/CFS because we tend to have low blood pressure as well as syncope or light-headedness when standing.

Low blood pressure makes it hard to pump adequate blood to the brain all the time and syncope is a sign that the brain doesn’t have enough blood. A number of studies have found problems with blood flow to the brain in ME/CFS.I am also concerned that changes in the circulatory system in the body produce conditions of periodic blood impairment to cells. Research from the Open Medicine Foundation has found that red blood cells in ME/CFS fail to deform and flow smoothly through small blood vessels, a situation which would cause cells to be periodically denied oxygen. Fisetin has been found to prevent I/R injury in the heart as well as the brain and protect mitochondria from the damaging effects of I/R injury.Fisetin, Leaky Gut & Microglial Activation.

ME/CFS patient have show elevated antibodies to LPS, a component of bacteria that inhabit the gut. When this component ends up in the blood stream in larger than normal quantities, it can potentially trigger sepsis, an often deadly inflammatory response to bacterial infection.While the quantity of LPS in the blood of ME/CFS patients doesn’t reach that of sepsis patients, one of our researchers has suggested that ME/CFS is like a slow, chronic sepsis.

One part of the body that circulating LPS affects is the brain and many of the symptoms of ME/CFS seem to emanate from the brain, in particular flu-like malaise and brain fog. In animals, LPS exposure causes a depression-like response that may be related to the sensations of fatigue, depression and malaise that people feel when exposed experimentally to LPS. Brain inflammation in general causes feeling of fatigue, malaise, pain and depressed and anxious mood, regardless of the trigger. This response is related to the activation of immune cells in the brain called microglia.

  • Fisetin inhibits the microglial inflammatory response to LPS, and reduces the depression-like response to LPS.
  • Fisetin may be able to broadly suppress brain inflammation caused by microglial activation, even if the cause is something other than LPS exposure.

For more about the involvement of brain inflammation and microglial inflammation in ME/CFS, check out Jarred Younger’s work. He is making really interesting progress with imaging brain inflammation in ME/CFS.Children with autism have also been found to have an ongoing neuroinflammatory process involving microglial activation.Fisetin Affects Pathways Connected to Autism☄️☄️mTOR is a molecule frequently implicated in the pathogenesis of autism. It is involved in the development of the brain and the communication between brain cells. ( Taube added : see Dr Alex Vasquez on NAC inhibiting mTOR ) In animal models, cow’s milk allergic animals show autistic symptoms when exposed to cow’s milk and this effect appears to be caused by ☄️☄️☄️increased mTOR signaling in the brain. My food allergies trigger autistic symptoms in me.

Fisetin inhibits mTOR signaling in the brain.

Fisetin also inhibits a molecule implicated in autism called p38 MAPK. p38 MAPK triggers microglial inflammation as well as ☄️high serotonin levels, which are often seen in autism. Glutathione is one of the most important antioxidants in the body. Oxidative stress is high in autism and in ME/CFS while glutathione is low (here and here) in both conditions. Animal studies suggest that fisetin is able to increase glutathione levels in the presence of oxidative stress.

Fisetin also counteracted a neurotoxin called aluminum chloride. Fisetin blocked aluminum chloride’s effects on inflammation and oxidative stress and protected against the neurobehavioral deficits alumnum chloride can cause, in part by restoring glutathione levels.

Fisetin With Mast Cell Stabilizers When I started taking fisetin, I was already on a very helpful mast cell stabilization regimen that includes ketotifen and Benadryl. I don’t know exactly what difference fisetin would have made for me without additional mast cell stabilization, but added to a mast cell stabilization regimen, fisetin is sort of like a wonder treatment for me.

Comment by Jeff A

Additional Notes

N-acetylcysteine and histamine/allergies

In my last post on vagus nerve and IBS, I noticed some of the discussion mention impacts on acetylcysteine. This caused me to wonder about NAC and histamines/allergies/Mast cell issues. I know someone with severe allergies that was advised to take NAC for liver support by her naturopath.

Since the late 1970s N-acetylcystein has been used as an antidote after paracetamol intoxication. The treatment is traditionally given as three consecutive infusions for 20 hours and 15 minutes. The total dose given is 300 mg/kg. Half of this amount is given as a bolus during the first 15 minutes of treatment. This regime has proven very efficient in avoiding liver injury. However, side effects, caused by histamine release, are common (10-15%). 

Simplified N-acetylcystein treatment after paracetamol overdose – new recommendations from Swedish Poisons Information Centre [2019]

Similar citations:

  • “exposure to antihistamines prior to NAC treatment may protect against these [anaphylactoid] reactions.” [2020]
  • ” Anti-histamine treatment (for NAC anaphylactoid drug reactions) was prescribed for 163 (11.0%) patients” [2019]
  • ” Previous studies suggest the incidence and severity of non-allergic anaphylactic reactions (NAARs) are influenced by the rate of acetylcysteine infusion.” [2015]
  • “N-acetylcysteine (NAC) enhances the release of histamine induced by the fluoride-calcium system” [1991]

Histamine now seems to be an important mediator of the response [to NAC], and there is evidence of variability in patient susceptibility, with females, and those with a history of asthma or atopy are particularly susceptible. … The pattern of reactions differs with oral and intravenous dosing, but reported frequency is at least as high with oral as intravenous. The reactions to the intravenous preparation result in similar clinical features to true anaphylaxis, including rash, pruritus, angioedema, bronchospasm, and rarely hypotension, but are caused by nonimmunological mechanisms.

Adverse reactions associated with acetylcysteine [2009]

Bottom Line

If you are female with histamine issues, asthma or allergies — taking NAC will make some of your worst or more sensitive. If your MD or ND have recommended NAC and you have told them about allergies, asthma etc. you should print this off to inform them. It has been known since at least 1991, just 30 years ago.

Vagus nerve stimulation and ME/CFS/IBS

A reader messaged me:

There reports of people improving using VNS recently; came across this.

https://bioelecmed.biomedcentral.com/articles/10.1186/s42234-018-0004-9
How could this affect the good vs bad bacteria in one’s microbiome?

A reader via facebook

 We have recently reported in a 6 month follow-up pilot study that VNS improves active Crohn’s disease. Preliminary data of another pilot study confirm this interest. Similarly, VNS has recently been reported to improve rheumatoid arthritis, another TNFα mediated disease

Is-there a place for vagus nerve stimulation in inflammatory bowel diseases? [2018]

As a starting point, let us look at how the mind impacts the microbiome due to stress. We see a relatively long list of bacteria associated with stress reported on the national library of medicine. The state of the mind impacts the microbiome; also the microbiome impacts the state of mind (depression, sleeplessness etc). Some readings:

The study above is also cited in

Back to a mechanical/chemical approach to the analysis. What do we know change with vagus nerve stimulation. Remember, a change of circulating chemicals will influence bacteria growth.

The central nervous system recognizes peripheral inflammation via afferent vagus nerve signaling. The brain can attenuate peripheral innate immune responses, including pro-inflammatory cytokine production, leukocyte recruitment, and nuclear factor kappa β activation via α7-nicotinic acetylcholine receptor subunit-dependent, T-lymphocyte-dependent, vagus nerve signaling to spleen.

The vagus nerve and the inflammatory reflex: wandering on a new treatment paradigm for systemic inflammation and sepsis [2012]

Bottom Line

Vagus nerve stimulation alters the chemicals in the body. Studies in mice with electronic stimulation indicate that it can make inflammation worse or better — depending on the parameters. There are a wide variety of methods to stimulate the vagus nerve — a few common ones[src] are:

  • Cold Exposure. …
  • Deep and Slow Breathing. …
  • Singing, Humming, Chanting and Gargling. …
  • Probiotics. …
  • Meditation. …
  • Omega-3 Fatty Acids.
  • Exercise. …
  • Massage.

The use of electronic means should be done with caution because the setting used can have an adverse effect (according to mice studies). This may also apply to exercise with ME/CFS.

While I could not find studies explicate for CFS/ME, I did find some for items often co-mobid with ME/CFS

I have concern over arbitrary vagus stimulation with ME/CFS, especially electronic means. I know too many people that have adverse reaction to exercise, humming, singing etc. In some of these cases, it is possible that the adverse reaction may be connected to a vagus nerve infection.

Is ME/CFS a case of CBIS?

A reader asked me to review a new paper “Chronic bacterial intoxication syndrome under the mask of CFS/ME” that is being discussed a lot on Phoenix Rising. I tend to have an interesting perspective:

  • being in remission from CFS/ME I have deep desired to be current but far from desperate
  • many people reading and discussing are desperate. Desperation often diminished critical analysis
  • I am well trained professionally — not only in the scientific method, but also in statistical analysis.

Key Weakness of CBIS paper

Over the last few decades, it is common for a forlorn hope discovery to be done solely on some finding of a group of ME/CFS patients. The critical test is a simple one: a third party lab confirming the findings with a different group of ME/CFS patients with a matching control/healthy group. The ideal is multiple labs confirming this. Failure to replicate is too frequently the slow death of theories (but many “believers” will continue to advocate the theory – they want something to believe in).

Participants: All patients (children up infancy and adults aged till 80 years) who seeked advice in
clinics during 2009-2020 with complaints consistent with a diagnosis of CFS, which was previously
diagnosed in almost a third of patients on former stages of examination and treatment.

There are no Controls being cited. Additionally all of the patients appears to be from two clinics in the Ukraine. This may be an environmentally homogenous group (shared DNA, shared diet, shared vaccine history).

In all patients with typical features of CFS there was revealed a focus of chronic bacterial infection
in the kidneys, which more often remained clinically locally asymptomatic and was called Nephro
dysbacteriosis.

The term “Nephro dysbacteriosis” is not found on PubMed, so how can it be “was called

The issue of being “asymptomatic” is a term of today, with asymptomatic COVID being an echo. The concept is not new, with hypercoagulation model — we have it being asymptomatic in terms of expected symptoms (strokes,  Deep Vein Thrombosis etc) but symptomatic with fertility issues. Similarly with Cecile Jadin model, we have “occult infections” which do not appear with typical tests, but are detected with specialized tests.

If it is true, what should be forecasted? Well, a chronic low level kidney infection should manifest itself with kidney diseases and lab tests over time. Over the last many decades, there appears to be only a single paper, with no commonality.

 Increases in pain distribution were associated with reductions in serum essential amino acids, urea, serum sodium and increases in serum glucose and the 24-hour urine volume; however the biochemistry was different for each pain area. Regression modelling revealed potential acetylation and methylation defects in the pain subjects. 

Widespread pain and altered renal function in ME/CFS patients[2016]”

Skipping the 14 pages of the paper is reciting history and many more pages on individual histories, we come to identification of the bacteria

Bacteria that had to live naturally in our intestines and work there productively, providing human life. But which, apparently by mistake, but purposefully settled in the kidneys. Most often they were enterococci and enterobacteria-Escherichia coli, Klebsiella, Proteus, Enterobacteriaceae, Morganella, Acinetobacteria, Hafnia,
Seratia and others, in no single cases – Staphylococcus and Streptococcus, less often – Nosocomial Pseudomonas aeruginosa.

“A toxicological blood test, the results of which will be presented in Report 8, was considered as a laboratory confirmation of the diagnosis CBIS.” – problem is this, a blood test is not kidney specific. We could be detecting bacteria escaping from the guts only.

Note also, this is not a test normally available — it is “a toxicological blood test using the “Toxicon” diagnostic system developed by a group of Ukrainian scientists

What is their treatment?

The treatment are “bacterial vaccines”. This is a concept not well known in the west and will likely be at least a decade before any significant approval would be granted in the west. A 2018 review is well worth readin , Vaccine development for enteric bacterial pathogens: Where do we stand? (Full article PDF). Two quotes from the paper:

“During the first course of immunization with bacterial autovaccine, the intensity of pain in all patients decreased
significantly, and after 2-3 courses – completely passed. During follow-up observation there were no recurrences of trigeminitis.”

“There was prepared bacterial auto vaccine and was carried out immunization with a course of 10 injections. Already during vaccination and for the next 2 years of the follow-up observation there were no more abdominal pain attacks.”

Attitude Issues

The following indicate bravado and bias — they can be effective in winning an audience and a following. Often this helps with raising funds for the person to continue research.

  • the new revolutionary previously unknown diagnosis Chronic Bacterial Intoxication Syndrome (CBIS) that gives such a long-awaited in-depth clinical understanding and discovery of the true basic etiological and pathogenetic causes of the long-known and worldwide-spread, but still etiologically mysterious CFS/ME”
  • “Moreover, it was found that in at least 90% of patient’s nephron dysbacteriosis and CBIS had developed precisely after thoughtless, expansive and aggressive antibiotic therapy, which often began in childhood.” — someone is on soap box describing a popular demon.

Bottom Line

A vaccine against a kidney bacteria will also have direct impact on the same bacteria in the gut microbiome. On the flip side, appropriate antibiotics would also impact the same bacteria in the Jadin’s protocol using antibiotics will also impact kidney infections.

There is one important difference: vaccines have a longer life of action(typically a year or more) than an antibiotics. Also be aware that the study cited that up to 10 courses of vaccines were needed with some. This sounds a bit like 10 rounds of antibiotics!!

Is it Kidney or Gut? Do we need to use a vaccine or bacteria phages or antibiotics or other forms of microbial manipulations?

Their asserted results are similar to that asserted from both Jadin’s antibiotics protocol and the Hemex protocol (which often uses antibiotics with anticoagulants like heparin).

In 30/35 (85.7%) cases there was almost complete clinical remission in the course of both fibromyalgia and in general CBIS, which in 23/35 (65.7%) patients lasted from 3 to 5 years (observation period).

page 48

The statement that in the basis of chronic fatigue in various diseases there is a single pathogenetic mechanism – persistent chronic bacterial intoxication due to nephrodisbacteriosis may be a little premature.

page 82.

To my mind, for treatment of CFS/ME, the root cause is excessive growth of multiple bacteria with both this model and my microbiome model. The goal is to correct this — vaccine, antibiotics, phages, diet and supplement changes? Whatever works. The key factor is that it is NOT a cure, it is a remission — one that needs to be worked on to maintain.

Until vaccines become available, appropriate multiple courses of the right antibiotics is available today (MD willing!!!). Unfortunately, most MDs are not trained on addressing multiple bacterial infection without nuking the gut.

Their results are creditable, their treatment is creditable — their model may not be

Fecal Matter Transplant for ME/CFS – 2023 Update

Just in, July 29, 2023 study:

FMT was safe but did not relieve symptoms or improve ... patients with CFS.

Randomized, double-blinded, placebo-controlled pilot study: efficacy of faecal microbiota transplantation on chronic fatigue syndrome [2023]

The earlier post from 2021 is below.

A reader wrote me with some good questions. My answer is focused on ME/CFS but the analysis applies to UC, Crohn’s, IBS, Sibo, Autism and every disease with distinctive microbiome shift (here’s a partial list).

My wife is considering a fecal microbiota transplant(FMT) because of her chronic (CFS/Fibromyalgia) complaints and tested leaky gut, SIBO and microbiome dysbiosis.

We’ve found a company that claims to deliver fully prepared stool of “super donors” for about $1900 all included. Do you know this company and do you think they are trustworthy in their claims? https://microbioma.org/en/home-eng/

Do you have any other advice for us in relation to FMT, for example other trustworthy companies maybe in the area that we live (Europe) or perhaps an evidence based warning that she should not do this?

Hope to hear from you.

A 2019 article is worth reading The potential and pitfalls of fecal transplants

FMT is effectively an Organ Transplant…

For conventional medicine, there is a 10-15% rejection rate with the use of medications to prevent rejection. The following are factors to consider for organ transplants and likely apply to fecal matter transplants.

  • Ensure recipient and donor have compatible blood types
  • Perform genetic testing to ensure compatible recipient and donor matches
  • In the case of living donors, donor organs from relatives are preferred

Blood Type

Not only should blood type be a factor, but secretor status. There should be a match – being a “super donor” implies a naïve understanding of FMT and transplants in general.

Generic Testing

There is little literature here. My own feeling is that we need at least strain level comparisons between donors and recipient having considerable agreement. The volumes may be different, but the strains should be similar for bacteria not associated with the condition (i.e. for ME/CFS those that are high in the species the list here ideally, those species will be missing). Adding a page to the website on this issue would not be too hard (when there is a demand for it).

Donations from relatives are preferred

Bacteriophage α-diversity is important!

In this retrospective analysis, FMTs with increased bacteriophage α-diversity were more likely to successfully treat rCDI. In addition, the relative number of bacteriophage reads was lower in donations leading to a successful FMT. These results suggest that bacteriophage abundance may have some role in determining the relative success of FMT.

The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study (2019)

Other Preparation tests

From Johns Hopkins: “A potential donor will need to be screened by their physician for infectious pathogens by undergoing the following tests:

  • Blood tests: Hepatitis A, B, and C serologies; HIV; RPR
  • Stool tests: Ova and parasites; C. difficile PCR; culture and sensitivity; giardia antigen”

Microbiome is a hot topic — hence money maker

Microbiome transplants, including “turkey baster DYI” are hot. A summary is given on WebMd. One of the few FDA approved sources is OpenBiome. You should note their scope of operation:

https://www.openbiome.org/regulatory

This reader cites, Microbioma.org. It is based in the Principality of Asturias, an  autonomous community in northwest Spain, I suspect that this is to avoid government oversight (i.e. “off-shore unregulated havens”). I could not find either hospital or universities or similar that are associated with them — there were no studies on PubMed citing this organization.

Ideally, this firm would provide 16s strain level data on all available donors. They claim using AI to match. While, having done AI for decades, I would want to see their algorithms because AI often is biased or simply wrong. With no publications (and thus peer review), there is no evidence that their AI works. Citing AI is a good marketing strategy.

A few years ago, the Dove Clinic for Integrate Medicine in the UK offered FMT for CFS. They no longer do but for leaky gut offers “Gut Flora Replacement Therapy

ME-Pedia on FMT

This page is current on FMT for ME/CFS. Australia allows it to occur for ME/CFS with Thomas J. Borody, MD and  Paul Froomes, MD being the best known. I observe the following:

Some of their patients have shared their experiences. It was not uncommon to hear “almost immediate remission that lasted about 6 weeks and then ME came back” followed by many additional FMT attempts.

Large treatment effects were observed for the intention-to-treat sample with a reduction in Streptococcus viable count and improvement on several clinical outcomes including total symptoms, some sleep (less awakenings, greater efficiency and quality) and cognitive symptoms (attention, processing speed, cognitive flexibility, story memory and verbal fluency). Mood, fatigue and urine D:L lactate ratio remained similar across time. Ancillary results infer that shifts in microbiota were associated with more of the variance in clinical changes for males compared with females.

Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons [2018]

“Based on the selected studies, the Adverse Effects(AE) rate of FMT is 39.3%, with most AE being mild and self-limiting. Severe Adverse Effects (SAE) were uncommon at 5.3%, and many were only possibly related to the FMT. ” i.e. 1/20 odds of SAE Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies [2021]

“However, while current FDA regulations permit use of FMT for treating C. difficile infections that
have not responded to standard antibiotic therapy, use of FMT for any other indication requires
submittal and approval of an IND (investigational new drug) application to the FDA.”

Fecal Microbiota Transplantation, Washington State Health Care Authority

“[FMT Capsules] is an unapproved new drug and unlicensed biological product, which was introduced or delivered for introduction into interstate commerce in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act) [21 U.S.C. § 331(d)] and the Public Health Service Act (PHS Act) [42 U.S.C. § 262(a)(1)]. …statements indicate that your product is intended for use in the mitigation, treatment, or prevention of disease, your product is a drug under section 201(g)(1)(B) of the FD&C Act [21 U.S.C. § 321(g)(1)(B)]. 
Please be advised that to lawfully market a drug that is also a biological product, a valid biologics license application (BLA) must be in effect [42 U.S.C. § 262(a)]. Such licenses are issued only after a demonstration that the product is safe, pure, and potent. While in the development stage, such products may be distributed for clinical use in humans only if the sponsor has an investigational new drug application (IND) in effect as specified by FDA regulations (21 U.S.C. § 355(i); 42 U.S.C. § 262(a)(3); 21 CFR Part 312). “

From existing FDA warning letters for other biological products

IMHO: Both the seller and any medical person involved would likely have no viable defense against lawsuits (all types). Remember, ignorance of the law (and the FDA) is not an acceptable excuse to the courts. If someone attempts to sell, ask for a copy of their BLA.

Bottom-Line

As with clostridium difficile (C.diff), FMT should only be done after repeated attempts with antibiotics have failed. My preference for antibiotic protocol would be that of Cecile Jadin, MD. Alternatively, determine the antibiotics via a microbiome analysis and using Microbiome Prescription for suggestions (see this recent post on a 20 y.o, CFS male— the antibiotic suggested agreed with the Jadin protocol).

The idea of using FMT for ME/CFS is correct in my opinion. The problem is the naïve attempts done without approaching typing and matching of the “organ” to be transplanted. Current attempts are almost like saying – oh he has lost a lot of blood, just give him blood — from an human, a race horse, a pig, a cow etc. Blood is blood…

Remember that FMT for C.diff has around 70% success rate. That is trying to dislodge a single bacteria. With ME/CFS there are likely dozens to be dislodged…. if it is 70% success for one, then it may be 50% success for two, 35% for three etc.

Personally, I prefer going the 16s microbiome analysis route, ideally with antibiotics and diet/supplement changes. FMT is too experimental and prone to trial and error. The reported success rate for the Jadin protocol is higher than that reported for FMT.

Some prior posts on this topic: